Back to Search
Start Over
Relative contributions of severe dopaminergic neuron ablation and dopamine depletion to cognitive impairment.
- Source :
-
Experimental neurology [Exp Neurol] 2015 Sep; Vol. 271, pp. 205-14. Date of Electronic Publication: 2015 Jun 14. - Publication Year :
- 2015
-
Abstract
- Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons and produces a movement disorder and cognitive impairment that becomes more extensive with the duration of the disease. To what extent cognitive impairment in advanced PD can be attributed to severe loss of dopamine (DA) signaling is not well understood. Furthermore, it is unclear if the loss of DA neurons contributes to the cognitive impairment caused by the reduction in DA signaling. We generated genetic mouse models with equally severe chronic loss of DA achieved by either extensive ablation of DA neurons or inactivation of DA synthesis from preserved neurons and compared their motor and cognitive performance. Motor behaviors were equally blunted in both models, but we observed that DA neuron ablation caused more severe cognitive deficits than DA depletion. Both models had marked deficits in cue-discrimination learning. Yet, deficits in cue-discrimination learning were more severe in mice with DA neuron ablation and only mice with DA neuron ablation had drastically impaired performance in spatial learning, spatial memory and object memory tests. These results indicate that while a severe reduction in DA signaling results in motor and cognitive impairments, the loss of DA neurons promotes more extensive cognitive deficits and suggest that a loss of additional factors that depend on DA neurons may participate in the progressive cognitive decline found in patients with PD.<br /> (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Anxiety chemically induced
Anxiety genetics
Benzazepines pharmacology
Benzothiazoles pharmacology
Cognition Disorders genetics
Diphtheria Toxin toxicity
Discrimination Learning drug effects
Discrimination Learning physiology
Disease Models, Animal
Dopamine Agonists pharmacology
Dopamine Plasma Membrane Transport Proteins genetics
Dopamine Plasma Membrane Transport Proteins metabolism
Dopaminergic Neurons drug effects
Gene Expression Regulation drug effects
Gene Expression Regulation genetics
Memory drug effects
Memory physiology
Mice
Mice, Transgenic
Motor Activity drug effects
Motor Activity genetics
Pramipexole
Psychomotor Performance drug effects
Psychomotor Performance physiology
Spatial Learning drug effects
Spatial Learning physiology
Tyrosine 3-Monooxygenase deficiency
Tyrosine 3-Monooxygenase genetics
Brain metabolism
Brain pathology
Cognition Disorders metabolism
Cognition Disorders pathology
Dopamine metabolism
Dopaminergic Neurons pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1090-2430
- Volume :
- 271
- Database :
- MEDLINE
- Journal :
- Experimental neurology
- Publication Type :
- Academic Journal
- Accession number :
- 26079646
- Full Text :
- https://doi.org/10.1016/j.expneurol.2015.06.013